SCHEMBL8339611

SCHEMBL8339611

CNC(=S)N(C)C(=O)C(CCCN=S(=O)=O)c1ccc(C)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8333490 0.87 — —
SCHEMBL8334475 0.86 CNR1 (0.33) —
SCHEMBL8340346 0.82 ALOX5 (0.32) —
SCHEMBL8339028 0.80 GAA (0.33) —
SCHEMBL8389782 0.77 GPR88 (0.36) —
SCHEMBL8335851 0.75 CNR2 (0.38) —
SCHEMBL8389972 0.73 ALDH1A1 (0.34) —
SCHEMBL8334203 0.71 GAA (0.34) —
SCHEMBL8338348 0.68 TDP1 (0.39) —
SCHEMBL8336011 0.67 LMNA (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback